Cui Cui
Stock Analyst at Jefferies
(4.35)
# 1,281
Out of 4,595 analysts
32
Total ratings
60%
Success rate
29.8%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 0241 Alibaba Health Information Technology Limited | Maintained: Buy | $8.00 → $5.30 | $3.59 | +47.63% | 2 | May 19, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $15.50 | $18.06 | -14.17% | 1 | Apr 3, 2026 | |
| HKG: 9966 Alphamab Oncology | Maintained: Buy | $9.60 | $7.47 | +28.51% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Maintained: Hold | $12.40 | $7.82 | +58.57% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $226.00 | $93.95 | +140.55% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $500.00 | $181.80 | +175.03% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $300.00 → $520.00 | $483.80 | +7.48% | 3 | Aug 19, 2025 | |
| HKG: 6618 JD Health International Inc. | Maintained: Buy | $60.00 → $88.00 | $39.40 | +123.35% | 3 | Aug 15, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Sell | $5.00 | $8.58 | n/a | 1 | Jul 30, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $45.00 | $38.74 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 → $60.00 | $51.80 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175.00 → $87.40 | $160.70 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 | $86.70 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.00 | $2.17 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.80 | $6.84 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.00 | $17.38 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110.00 | $37.72 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 → $35.20 | $25.96 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.00 → $25.00 | $32.18 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $16.72 | n/a | 1 | Apr 22, 2020 |
Alibaba Health Information Technology Limited
May 19, 2026
Maintained: Buy
Price Target: $8.00 → $5.30
Current: $3.59
Upside: +47.63%
Genscript Biotech Corporation
Apr 3, 2026
Maintained: Buy
Price Target: $15.50
Current: $18.06
Upside: -14.17%
Alphamab Oncology
Mar 27, 2026
Maintained: Buy
Price Target: $9.60
Current: $7.47
Upside: +28.51%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Maintained: Hold
Price Target: $12.40
Current: $7.82
Upside: +58.57%
Akeso, Inc.
Oct 19, 2025
Maintained: Buy
Price Target: $226.00
Current: $93.95
Upside: +140.55%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Maintained: Buy
Price Target: $500.00
Current: $181.80
Upside: +175.03%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Maintained: Buy
Price Target: $300.00 → $520.00
Current: $483.80
Upside: +7.48%
JD Health International Inc.
Aug 15, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $39.40
Upside: +123.35%
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Maintained: Sell
Price Target: $5.00
Current: $8.58
Upside: n/a
WuXi Biologics (Cayman) Inc.
Mar 31, 2025
Maintained: Buy
Price Target: $45.00
Current: $38.74
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $41.00 → $60.00
Current: $51.80
Upside: n/a
Mar 21, 2025
Maintained: Buy
Price Target: $175.00 → $87.40
Current: $160.70
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $40.00
Current: $86.70
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $4.00
Current: $2.17
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $10.80
Current: $6.84
Upside: n/a
Nov 3, 2023
Maintained: Buy
Price Target: $26.00
Current: $17.38
Upside: n/a
Oct 31, 2023
Maintained: Buy
Price Target: $110.00
Current: $37.72
Upside: n/a
Oct 27, 2023
Maintained: Buy
Price Target: $40.00 → $35.20
Current: $25.96
Upside: n/a
Sep 4, 2023
Maintained: Buy
Price Target: $28.00 → $25.00
Current: $32.18
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $16.72
Upside: n/a